|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q2 FY2012
As of Jul 1, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| LICENSES FOR TECHNOLOGY (Note 4) | ||||||||||||||||||||
| INTANGIBLE ASSET (Note 5) | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Loan payable to director (Note 8) | ||||||||||||||||||||
| Loan payable to related party (Note 5) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| STOCKHOLDERS' DEFICIENCY | ||||||||||||||||||||
| Capital Stock ($.001 par value, 300,000,000 common shares authorized, 100,225,228 issued and outstanding as of September 30, 2018 and 100,195,228 as of December 31, 2017 | ||||||||||||||||||||
| Additional paid-in Capital | ||||||||||||||||||||
| Deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Stockholders' Deficiency Attributable to the Companys Stockholders | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total FNEC Stockholders' Deficit | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY | ||||||||||||||||||||
Loading...
